Published in J Neurosci Methods on January 20, 2012
Primary neuron culture for nerve growth and axon guidance studies in zebrafish (Danio rerio). PLoS One (2013) 0.89
Analysis of embryonic and larval zebrafish skeletal myofibers from dissociated preparations. J Vis Exp (2013) 0.81
Magnetic-activated cell sorting (MACS) can be used as a large-scale method for establishing zebrafish neuronal cell cultures. Sci Rep (2015) 0.80
Effective targeted gene 'knockdown' in zebrafish. Nat Genet (2000) 14.40
The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn (2007) 8.86
Animal models of human disease: zebrafish swim into view. Nat Rev Genet (2007) 8.36
Axonal transport and neurodegenerative disease. Biochim Biophys Acta (2006) 3.06
High-frequency generation of transgenic zebrafish which reliably express GFP in whole muscles or the whole body by using promoters of zebrafish origin. Dev Biol (1997) 3.03
Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev Biol (2000) 2.93
Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations. Development (2005) 2.30
Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet (2009) 2.23
GFAP transgenic zebrafish. Gene Expr Patterns (2006) 2.01
Development and axonal outgrowth of identified motoneurons in the zebrafish. J Neurosci (1986) 1.96
Targeted gene expression by the Gal4-UAS system in zebrafish. Dev Growth Differ (2008) 1.44
Characterization of a cell line derived from zebrafish (Brachydanio rerio) embryos. In Vitro Cell Dev Biol Anim (1993) 1.39
IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis (2004) 1.39
Zebrafish as a model for caveolin-associated muscle disease; caveolin-3 is required for myofibril organization and muscle cell patterning. Hum Mol Genet (2005) 1.34
A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J Clin Invest (2009) 1.32
Pathway selection by growth cones of identified motoneurones in live zebra fish embryos. Nature (1986) 1.31
Zebrafish: a complete animal model for in vivo drug discovery and development. Curr Drug Metab (2009) 1.27
Genetic zebrafish models of neurodegenerative diseases. Neurobiol Dis (2010) 1.17
Electroporation-based methods for in vivo, whole mount and primary culture analysis of zebrafish brain development. Neural Dev (2007) 1.16
Zebrafish: an integrative system for neurogenomics and neurosciences. Prog Neurobiol (2010) 1.15
Review: The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol (2011) 1.04
Transgenic zebrafish models of neurodegenerative diseases. Brain Struct Funct (2010) 1.02
Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Dev Neurobiol (2009) 1.02
High-throughput selection of retrovirus producer cell lines leads to markedly improved efficiency of germ line-transmissible insertions in zebra fish. J Virol (2002) 1.01
Control of motor axon guidance in the zebrafish embryo. Brain Res Bull (2000) 0.97
Genetic and transcriptome characterization of model zebrafish cell lines. Zebrafish (2006) 0.94
Real-time imaging of mitochondria in transgenic zebrafish expressing mitochondrially targeted GFP. Biotechniques (2008) 0.93
Preparation of dissociated zebrafish spinal neuron cultures. Methods Cell Sci (2001) 0.93
Cell cultures derived from early zebrafish embryos differentiate in vitro into neurons and astrocytes. Cytotechnology (1997) 0.92
In the swim of things: recent insights to neurogenetic disorders from zebrafish. Trends Genet (2010) 0.91
Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro. Neuromolecular Med (2004) 0.90
The zebrafish ennui behavioral mutation disrupts acetylcholine receptor localization and motor axon stability. Dev Neurobiol (2008) 0.89
Clustering of muscle acetylcholine receptors requires motoneurons in live embryos, but not in cell culture. J Neurosci (1992) 0.87
Microinjection and cell transplantation in zebrafish embryos. Methods Mol Biol (2008) 0.86
Motoneuronal development in the embryonic zebrafish. Development (1991) 0.85
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature (2007) 3.91
Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care (2006) 3.47
Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death". Acad Med (2012) 3.43
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care (2010) 3.20
A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development (2007) 2.92
Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev (2004) 2.83
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care (2006) 2.64
Diabetic neuropathy: mechanisms to management. Pharmacol Ther (2008) 2.57
Kindlin-2 is an essential component of intercalated discs and is required for vertebrate cardiac structure and function. Circ Res (2008) 2.48
Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet (2009) 2.23
High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J (2002) 2.18
Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes (2009) 1.99
Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol (2012) 1.99
Stem cell technology for neurodegenerative diseases. Ann Neurol (2011) 1.93
Microvascular complications of impaired glucose tolerance. Diabetes (2003) 1.88
Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells (2012) 1.87
Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol (2011) 1.85
Aligned electrospun nanofibers specify the direction of dorsal root ganglia neurite growth. J Biomed Mater Res A (2007) 1.83
Mouse models of diabetic neuropathy. Neurobiol Dis (2007) 1.76
Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J (2005) 1.75
Congenital myopathies: an update. Curr Neurol Neurosci Rep (2012) 1.66
Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes (2009) 1.64
Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev (2011) 1.62
How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol (2010) 1.60
Control of cell survival by IGF signaling pathways. Growth Horm IGF Res (2002) 1.56
The measurement of body segment inertial parameters using dual energy X-ray absorptiometry. J Biomech (2002) 1.55
Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst (2009) 1.52
Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev (2012) 1.51
SciMiner: web-based literature mining tool for target identification and functional enrichment analysis. Bioinformatics (2009) 1.45
SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J (2009) 1.45
Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol (2008) 1.44
Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology (2006) 1.44
CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum Mol Genet (2010) 1.44
Negative feedback regulation of FGF signaling levels by Pyst1/MKP3 in chick embryos. Curr Biol (2003) 1.42
Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord (2008) 1.40
Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology (2009) 1.39
IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis (2004) 1.39
SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Exp Neurol (2007) 1.38
The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst (2008) 1.36
The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons. Acta Biomater (2008) 1.36
Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy. Nat Commun (2013) 1.35
Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB J (2004) 1.33
Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiol Dis (2006) 1.33
Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 1.32
Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J. PLoS Genet (2011) 1.27
Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery (2012) 1.27
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst (2003) 1.26
Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci U S A (2010) 1.26
Mitochondrial DNA (mtDNA) biogenesis: visualization and duel incorporation of BrdU and EdU into newly synthesized mtDNA in vitro. J Histochem Cytochem (2010) 1.24
Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy. J Clin Invest (2014) 1.24
Design and responses of Butterworth and critically damped digital filters. J Electromyogr Kinesiol (2003) 1.23
Prevalence of congenital myopathies in a representative pediatric united states population. Ann Neurol (2011) 1.22
Signaling mechanisms that regulate actin-based motility processes in the nervous system. J Neurochem (2002) 1.22
Kindlin-2 is required for myocyte elongation and is essential for myogenesis. BMC Cell Biol (2008) 1.22
Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol (2006) 1.19
Insulin resistance in the nervous system. Trends Endocrinol Metab (2012) 1.18
DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep (2010) 1.18
Accelerated neuritogenesis and maturation of primary spinal motor neurons in response to nanofibers. Dev Neurobiol (2010) 1.17
Stem cell technology for the study and treatment of motor neuron diseases. Regen Med (2011) 1.16
Update on diabetic neuropathy. Curr Opin Neurol (2002) 1.16
Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathol (2010) 1.16
The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst (2004) 1.15
The integrin coactivator kindlin-2 plays a critical role in angiogenesis in mice and zebrafish. Blood (2011) 1.14
Criteria for creating and assessing mouse models of diabetic neuropathy. Curr Drug Targets (2008) 1.14
Clinical and molecular basis of classical lissencephaly: Mutations in the LIS1 gene (PAFAH1B1). Hum Mutat (2002) 1.13
Neb: a zebrafish model of nemaline myopathy due to nebulin mutation. Dis Model Mech (2011) 1.12
The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain (2011) 1.12
Membrane traffic and muscle: lessons from human disease. Traffic (2008) 1.12
Neuroinflammation, COX-2, and ALS--a dual role? Exp Neurol (2004) 1.10
Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network. BMC Immunol (2011) 1.08
New insights into the mechanisms of diabetic neuropathy. Rev Endocr Metab Disord (2004) 1.08
Abnormal muscle spindle innervation and large-fiber neuropathy in diabetic mice. Diabetes (2008) 1.07
Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone. Cancer Res (2006) 1.07
Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs. Spine (Phila Pa 1976) (2011) 1.07
Kindlin-2 regulates hemostasis by controlling endothelial cell-surface expression of ADP/AMP catabolic enzymes via a clathrin-dependent mechanism. Blood (2013) 1.06
Specification and maintenance of the spinal cord stem zone. Development (2005) 1.06
Substrate patterning: an emerging technology for the study of neuronal behavior. Exp Neurol (2003) 1.06
Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. J Neuropathol Exp Neurol (2009) 1.06
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice. Endocrinology (2008) 1.06
Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis (2008) 1.06
Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care (2010) 1.05
Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. Muscle Nerve (2009) 1.05
Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes. Neurosurgery (2014) 1.04
Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. Antioxid Redox Signal (2009) 1.04
Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores. Am J Hum Genet (2012) 1.04
Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes. Diabetes (2011) 1.04
The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice. Neurosci Lett (2010) 1.03
N-Myc overexpression leads to decreased beta1 integrin expression and increased apoptosis in human neuroblastoma cells. Oncogene (2003) 1.03
Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. Hum Mol Genet (2011) 1.03
Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. Antioxid Redox Signal (2005) 1.02
Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Dev Neurobiol (2009) 1.02
Skeletal muscle weakness due to deficiency of CuZn-superoxide dismutase is associated with loss of functional innervation. Am J Physiol Regul Integr Comp Physiol (2011) 1.01
Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. Endocrinology (2011) 1.01
Insulin-like growth factors in the peripheral nervous system. Endocrinology (2008) 1.00
Insulin-like growth factor-I signaling in human neuroblastoma cells. Oncogene (2004) 0.99
Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS One (2012) 0.99